SCHEMBL4518985

SCHEMBL4518985

CC(=O)c1c(O)c2cccnc2[nH]c1=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.53
PARP1 P09874 1/20 0.53
FGFR1 P11362 1/20 0.49
FLT1 P17948 1/20 0.49
KDM4E B2RXH2 5/20 0.48
MAPT P10636 2/20 0.48
POLB P06746 1/20 0.48
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2A Q12879 1/20 0.46
GRIN2B Q13224 1/20 0.46
GRIN2C Q14957 1/20 0.46
GRIN3A Q8TCU5 1/20 0.46
DAO P14920 1/20 0.45
FEN1 P39748 1/20 0.44
KDM5A P29375 3/20 0.44
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
PADI4 Q9UM07 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3515033 0.86 AURKA (0.54) AURKAPARP1FGFR1FLT1KDM4E
SCHEMBL25432963 0.85 AURKA (0.53) AURKAPARP1FGFR1FLT1KDM4E
SCHEMBL30590365 0.85 AURKA (0.53) AURKAPARP1FGFR1FLT1KDM4E
SCHEMBL8852978 0.85 AURKA (0.53) AURKAPARP1FGFR1FLT1KDM4E
SCHEMBL3624547 0.81 AURKA (0.49) AURKAPARP1FGFR1FLT1KDM4E
SCHEMBL1063233 0.81 KDM5A (0.62) KDM4EMAPTKDM5AALDH1A1GAA
SCHEMBL13968389 0.79 AURKA (0.45) AURKAPARP1FGFR1FLT1KDM4E
SCHEMBL822253 0.78 FTO (0.50) AURKAPARP1FGFR1FLT1KDM4E
SCHEMBL30305118 0.78 CNR2 (0.53) AURKAPARP1FGFR1FLT1KDM4E
SCHEMBL30305110 0.77 CNR2 (0.54) AURKAPARP1FGFR1FLT1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 US disclosed
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 US disclosed
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 US disclosed
EP-1857104-A1 USE OF CINNAMOYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed
EP-1857104-A1 USE OF CINNAMOYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143368-A1 Use of Cinnamoyl Compound COL2A1, COL1A1, SMAD2 AURKA 3476/4885PARP1 3025/4885FGFR1 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.